Medical sequelae of addiction

Clinical Addiction Psychiatry

Volumn , Issue , 2010, Pages 24-36

  Weaver, Michael ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886643283     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511782107.004     Document Type: Chapter

References (86)

1. Abraham, H. D., Aldridge, A. M. & Gogia, P. (1996). The psychopharmacology of hallucinogens. Neuropsychopharmacology,14, 285–98.
2. Agius, A. M., Smallman, L. A. & Pahor, A. L. (1998). Age, smoking, and nasalciliary beat frequency. Clinical Otolaryngology,23, 227–30.
3. American Psychiatric Association(APA). (2000). Diagnostic and Statistical Manual of Mental Disorders, 4Thedn, text revision. Washington DC: American Psychiatric Association.
4. Ballantyne, J. C. & Mao, J. (2003). Opioid therapy for chronic pain. New England Journal of Medicine,349, 1943–53.
5. Barsky, S. H., Roth, M. D., Kleerup, E. C. et al. (1998). Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. Journal of the National Cancer Institute,90, 1198–1205.
6. Barton, M., Dubey, R. K. & Traupe, T. (2002). Oral contraceptives and the risk of thrombosis and atherosclerosis. Expert Opinion on Investigational Drugs,11, 329–32.
7. Beaconsfi eld, P., Ginsburg, J. & Rainsbury, R. (1972). Marihuana smoking. Cardiovascular effects in man and possible mechanisms. New England Journal of Medicine,287, 209–12.
8. Bogart, L., Bonsignore, J. & Carvalho, A. (1986). Massive hemolysis following inhalation of volatile nitrites. American Journal of Hematology,22, 327.
9. Bolla, K. I., Brown, K., Eldreth, D. et al. (2002). Dose-related neurocognitive effects of marijuana use. Neurology,59, 1337–43.
10. Budney, A. J., Hughes, J. R., Moore, B. A. & Vandrey, R. (2004). Review of the validity and signifi cance of cannabis withdrawal syndrome. American Journal of Psychiatry,161, 1967–77.
11. Centers for Disease Control. (2005). Cigarette smoking among adults– United States, 2004. Morbidity and Mortality Weekly Report,54, 1121–4.
12. Chiriboga, C. A. (2003). Fetal alcohol and drug effects. Neurologist,9, 267–79.
13. Cicero, T. J., Inciardi, J. A. & Munoz, A. (2005). Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004. Journal of Pain,6, 662.
14. Compton, W. M., Grant, B. F., Colliver, J. D. et al. (2004). Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. Journal of the American Medical Association,291, 2114–21.
15. Cramer, C. & Davidhizar, R. (1999). FAS/FAE: impact on children. Journal of Child Health Care,3, 31–4.
16. Criqui, M. H. (2001). Peripheral arterial disease: epidemiologic aspects. Vascular Medicine 6(Suppl. 3), 3–7.
17. Cushman, P. Jr. (1987). Delirium tremens: update on an old disorder. ostgraduate Medicine,82, 117–22.
18. Deutsch-Wenzel, R., Brune, H. & Grimmer, G. (1983). Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. Journal of the National Cancer Institute,71, 539–44.
19. Eliasson, B. (2003). Cigarette smoking and diabetes. Progress in Cardiovascular Diseases,45, 405–13.
20. Ernst, T., Chang, L., Leonido-Yee, M. & Speck, O. (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology, 54, 1344.
21. Fernandez-Ruiz, J., Gomez, M., Hernandez, M. et al. (2004). Cannabinoids and gene expression during brain development. Neurotoxicity Research,6, 389–401.
22. Fried, P. A. & Watkinson, B. (1990). 36- and 48-month neurobehavioral followup of children prenatally exposed to marijuana, cigarettes, and alcohol. Journal of Developmental and Behavioral Pediatrics, 11, 49–58.
23. Glantz, S. A. & Parmley, W. W. (1995). Passive smoking and heart disease: mechanisms and risk. Journal of the American Medical Association,273, 1047–53.
24. Gocze, P. M., Szabo, I. & Freeman, D. A. (1999). Infl uence of nicotine, cotinine, anabasine and cigarette smoke extract on human granulosa cell progesterone and estradiol synthesis. Gynecological Endocrinology,13, 266–72.
25. Gold, M. S., Frost-Pineda, K. & Jacobs, W. S. (2004). Cannabis. In Textbook of Substance Abuse Treatment, 3rd edn, eds. M. Galanter & H. Kleber. Washington DC: American Psychiatric Publishing, pp.167–88.
26. Gong, H. Jr, Fligiel, S., Tashkin, D. P. & Barbers, R. G. (1987). Tracheobronchial changes in habitual, heavysmokers of marijuana with and without tobacco. American Review of Respiratory Diseases,136, 142–9.
27. Gourgou, S., Dedieu, F. & Sancho-Garnier, H. (2002). Lower limb venous insuffi ciency and tobacco smoking. A merican Journal of Epidemiology,155, 1007–15.
28. Gouzoulis-Mayfrank, E., Daumann, J., Tuchtenhagen, F. et al. (2000). Impaired cognitive performance in drug free users of recreational ecstasy(MDMA). Journal of Neurology, Neurosurgery and Psychiatry,68, 719.
29. Gronbladh, L., Ohlund, L. S. & Gunne, L. M. (1990). Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatrica Scandinavica,82, 223.
30. Grunkemeier, D. M., Cassara, J. E., Dalton, C. B. & Drossman, D. A. (2007). The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clinical Gastroenterology and Hepatology,5, 1126.
31. Hecht, S. S. (2006). Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbeck’s Archives of Surgery,391, 603–13.
32. Henry, J. A., Jeffreys, K. J. & Dawling, S. (1992). Toxicity and deaths from 3,4-methylenedioxymethamphetamine(“ecstasy”). Lancet,340, 384.
33. Higgitt, A., Fonagy, P., Toone, B. & Shine, P. (1990). The prolonged benzodiazepine withdrawal syndrome: anxiety or hysteria? Acta Psychiatrica Scandinavica,82, 165.
34. Howe, C. J., Fuller, C. M., Ompad, D. C. et al. (2005). Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug and Alcohol Dependence,79, 389.
35. International Agency for Research on Cancer(IARC). (2004). Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83. Lyon, France: IARC, pp. 1179–87.
36. Iversen, L. (2003). Cannabis and the brain. Brain,126, 1252–70.
37. Jansen, K. L. R. (1993). Non-medical use of ketamine. British Medical Journal,306, 601–2.
38. Johnson, M. K., Smith, R. P., Morrison, D. et al. (2000). Large lung bullae in marijuana smokers. Th orax,55, 340–2.
39. Johnston, L. D., O’Malley, P. M. & Bachman, J. G. (2003). Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, NIH Pub. No. 03–5374. Bethesda, MD: National Institute on Drug Abuse.
40. Johnston, L. D., O’Malley, P. M. & Bachman, J. G. (2002). Monitoring the Future National Survey Results on Drug Use, 1975–2001, Vol. 1: Secondary School Students. Rockville, Maryland: National Institute on Drug Abuse.
41. Kamholz, S. L. (2006). Pulmonary and cardiovascular consequences of smoking. Clinics in Occupational and Environmental Medicine,5, 157–71.
42. Karan, L. D., Dani, J. A. & Benowitz, N. (2003). The pharmacology of nicotine and tobacco. In Principles of Addiction Medicine, 3rd edn, eds. A. W. Graham & T. K. Shultz. Chevy Chase, MD: American Society of Addiction Medicine, Inc., pp. 225–48.
43. Klein, T. W., Friedman, H. & Specter, S. (1998). Marijuana, immunity and infection. Journal of Neuroimmunology, 83, 102–15.
44. Kolodny, R. C., Masters, W. H., Kolodner, R. M. & Toro, G. (1974). Depression of plasma testosterone levels aft er chronic intensive marihuana use. New England Journal of Medicine,290, 872–4.
45. Laumon, B., Gadegbeku, B., Martin, J. L. et al. (2005). Cannabis intoxication and fatal road crashes in France: population based case-control study. British Medical Journal,331, 1371–6.
46. Lolin, Y. (1989). Chronic neurological toxicity associated wiThexposure to volatile substances. Human Toxicology,8, 293.
47. Mackay, J. & Eriksen, M. (2002). The Tobacco Atlas. Geneva: World Health Organization, pp. 24–7.
48. Mallampalli, A. & Guntupalli, K. K. (2006). Smoking and systemic disease. Clinics in Occupational and Environmental Medicine,5, 173–92.
49. Marjot, R. & McLeod, A. A. (1989). Chronic nonneurological toxicity from volatile substance abuse. Human Toxicology,8, 301.
50. Mittleman, M. A., Lewis, R. A., Maclure, M. et al. (2001). Triggering myocardial infarction by marijuana. Circulation,103, 2805–9.
51. Moskowitz, D. (1971). Use of haloperidol to reduce LSD fl ashbacks. Military Medicine,136, 754–6.
52. Mueller, B. A., Daling, J. R., Weiss, N. S. & Moore, D. E. (1990). Recreational drug use and the risk of primary infertility. Epidemiology,1, 195–200.
53. Naditch, M. P. (1974). Acute adverse reactions to psychoactive drugs, drug usage, and psychopathology. Journal of Abnormal Psychology,83, 394–403.
54. Otsuka, R., Watanabe, H., Hirata, K. et al. (2001). Acute effects of passive smoking on the coronary circulation in healthy young adults. Journal of the American Medical Association,286, 436–41.
55. Pagliaro, A. M. & Pagliaro, L. A. (2003). Alcohol and other drug use during pregnancy: eff ect on the developing fetus, neonate, and infant. In Principles of Addiction Medicine, 3rd edn, eds. A. W. Graham & T. K. Shultz. Chevy Chase, MD: American Society of Addiction Medicine, Inc., pp. 1247–58.
56. Prummer, M. F. & Wiersinga, W. M. (1993). Smoking and risk of Grave’s disease. Journal of the American Medical Association,269, 479–82.
57. Schuckit, M. A. & Tapert, S. (2004). Alcohol. In Textbook of Substance Abuse Treatment, 3rd edn, eds. M. Galanter & H. Kleber. Washington DC: American Psychiatric Publishing, pp. 151–66.
58. Seger, D. L. (2004). Flumazenil– treatment or toxin. Journal of Toxicology– Clinical Toxicology,42, 209–16.
59. Shepherd, R. T. (1989). Mechanism of sudden death associated with volatile substance abuse. Human Toxicology,8, 287.
60. Silverman, R. A., Boudreaux, E. D., Woodruff, P. G. et al. (2003). Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest,123, 1472–9.
61. Sidney, S. (2003). Comparing cannabis with tobacco– again. British Medical Journal,327, 635–6.
62. Smith, S. M. (1997). Alcohol-induced cell death in the embryo. Alcohol Health & Research World,21, 287–97.
63. Sporer, K. A. (1999). Acute heroin overdose. Annals of Internal Medicine,130, 584–90.
64. Sridhar, K. S., Raub, W. A. Jr, Weatherby, N. L. et al. (1994). Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. Journal of Psychoactive Drugs,26, 285–8.
65. Strassman, R. J. (1984). Adverse reactions to psychedelic drugs: a review of the literature. Journal of Nervous and Mental Disease,172, 577–95.
66. Substance Abuse and Mental Health Services Administration. (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings (Offi ce of Applied Studies, NSDUH Series H-30. Rockville, MD: DHHS Publication No. SMA 06–4194).
67. Tashkin, D. P., Shapiro, B. J., Lee, Y. E. & Harper, C. E. (1976). Subacute effects of heavy marihuana smoking on pulmonary function in healthy men. New England Journal of Medicine,294, 125–9.
68. Tashkin, D. P., Coulson, A. H., Clark, V. A. et al. (1987). Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. American Review of Respiratory Diseases, 135, 209–16.
69. Taylor, B. V., Oudit, G. Y., Kalman, P. G. et al. (1998). Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system. Canadian Journal of Cardiology,14, 1129–39.
70. Taylor, D. R., Fergusson, D. M., Milne, B. J. et al. (2002). A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction,97, 1055–61.
71. Th ompson, P. M., Hayashi, K. M., Simon, S. L. et al. (2004). Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience,24, 6028.
72. Toomey, R., Lyons, M. J., Eisen, S. A. et al. (2003). A twin study of the neuropsychological consequences of stimulant abuse. Archives of General Psychiatry,60, 303.
73. Tortu, S., McMahon, J. M., Pouget, E. R. & Hamid, R. (2004). Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Substance Use & Misuse, 39, 211.
74. Turner, R. C., Lichstein, P. R., Peden, J. G. Jr, Busher, J. T. & Waivers, L. E. (1989). Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment. Journal of General Internal Medicine,4, 432–44.
75. Vine, M. F. (1996). Smoking and male reproduction: a review. International Journal of Andrology, 19, 323–37.
76. Weaver, M. F. (2003). Perinatal addiction. In Principles of Addiction Medicine, 3rd edn, eds. A. W. Graham & T. K. Shultz. Chevy Chase, MD: American Society of Addiction Medicine, Inc., pp. 1231–46.
77. Weaver, M. F. & Schnoll, S. H. (1999). Stimulants–amphetamines, cocaine. In Addictions: A Comprehensive Guidebook, eds. B. S. McCrady & E. E. Epstein. New York: Oxford University Press, p. 105.
78. Weaver, M. F. & Schnoll, S. H. (2007a). Addiction issues in prescribing opioids for chronic nonmalignant pain. Journal of Addiction Medicine,1, 2–10.
79. Weaver, M. F. & Schnoll, S. H. (2007b). Phencyclidine and ketamine. In Treatments of Psychiatric Disorders, 4Thedn, ed. G. O. Gabbard. Washington DC: American Psychiatric Publishing, Inc., pp. 271–80.
80. Weaver, M. F., Jarvis, M. A. E. & Schnoll, S. H. (1999). Role of the primary care physician in problems of substance abuse. Archives of Internal Medicine,159, 913–24.
81. Wiesbeck, G. A., Schuckit, M. A., Kalmijn, J. A. et al. (1996). An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction, 1, 1469–78.
82. Wilson, R. & Rayner, C. F. (1995). Bronchitis. Current Opinion in Pulmonary Medicine,1, 177–82.
83. Wu, L. T., Schlenger, W. E. & Galvin, D. M. (2006). Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and fl unitrazepam among American youths. Drug and Alcohol Dependence,84, 102–13.
84. Wu, T. C., Tashkin, D. P., Djahed, B. & Rose, J. E. (1988). Pulmonary hazards of smoking marijuana as compared with tobacco. New England Journal of Medicine,318, 347–51.
85. Zevin, S., Saunders, S., Gourlay, S. G. et al. (2001). Cardiovascular effects of carbon monoxide and cigarette smoking. Journal of the American College of Cardiology,38, 1633–8.
86. Zuckerman, B., Frank, D. A., Hingson, R. et al. (1989). effects of maternal marijuana and cocaine on fetal growth. New England Journal of Medicine,320, 762–68.